Esophageal dilator market seen reaching $1.99 billion by 2030

The esophageal dilator market is projected to rise from $1.57 billion in 2025 to $1.99 billion by 2030, according to The Business Research Company. Growth is being driven by rising esophageal disease rates, wider use of minimally invasive procedures and demand for newer dilator technologies.

Why it matters: - Esophageal dilators are used to widen narrowed areas of the esophagus and help relieve swallowing problems tied to strictures and other esophageal conditions. - The market’s projected growth points to continued demand for treatments that support faster recovery, better precision and less invasive care. - Rising esophageal disease burden increases the number of patients who may need dilation procedures.

What happened: - The Business Research Company said the esophageal dilator market will grow from $1.57 billion in 2025 to $1.65 billion in 2026. - The company projects the market will reach $1.99 billion by 2030. - The forecast implies a 5.2% CAGR from 2025 to 2026 and a 4.8% CAGR through 2030. - North America held the largest market share in 2025.

The details: - The market’s recent expansion has been supported by limited availability of advanced esophageal dilators, continued use of traditional mechanical dilators, higher awareness of esophageal disorders and broader hospital and clinic infrastructure. - Future growth is expected to come from controlled-release and pre-loaded balloon dilators, wider use of flexible and hydrostatic dilators, more ambulatory surgical centers, an aging population and improvements in materials and guided procedure technologies. - Key trends include stronger demand for minimally invasive procedures, growing preference for balloon and hydrostatic dilators, more esophageal disease cases, greater focus on patient safety and precision, and the use of advanced materials for durability and flexibility. - The market analysis also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - A free sample report is available here. - The full report is available here.

Between the lines: - The forecast suggests growth is coming less from one breakthrough product and more from incremental adoption of better-designed dilators and broader procedure use. - North America’s lead likely reflects stronger healthcare access, faster uptake of new devices and higher awareness of esophageal conditions. - The emphasis on minimally invasive care tracks with wider procedural trends across medicine, not just in this niche market.

What's next: - Market growth will likely depend on how quickly hospitals, clinics and ambulatory surgical centers adopt newer balloon, hydrostatic and guided-dilation tools. - Demand may rise further if esophageal disease rates continue to increase and the population ages. - The company’s report package is aimed at helping buyers track market size, competitive positioning and forecast changes.